Kelly H Roy
Physician in Phoenix, AZ

License number
Utah 7993202-8905
Issued Date
Jul 21, 2011
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Phoenix, AZ
Education
UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE

Organization information

See more information about Kelly H Roy at bizstanding.com

KELLY H. ROY, M.D., PC

3410 N 4 Ave, Phoenix, AZ 85013

Industry:
Internist, Obgyn
Doing business as:
Kelly H Roy, MD
Registration:
Feb 5, 2004
Phone:
(602) 241-1944 (Phone)
State ID:
-1116235-4
Expiration:
PERPETUAL
Presidents:
Robert Hallett (Other officer), 209 W Lamar Rd, Phoenix, AZ 85013 (Physical),Kelly H Roy M D (President), 209 W Lamar Rd, Phoenix, AZ 85013 (Physical)
Agent:
Dickinson Wright Pllc,1850 N Central Ave STE 1400, Phoenix, AZ 85004 (Physical)


Phoenix Gynecology Consulta - Kelly H Roy MD

3410 N 4 Ave, Phoenix, AZ 85013

Categories:
Gynecology & Obstetrics Physicians & Surgeons, Physicians & Surgeons
Phone:
(602) 305-1944 (Phone)

Professional information

Kelly H Roy Photo 1

Dr. Kelly H Roy - MD (Doctor of Medicine)

Hospitals:
Phoenix
1008 E Mcdowell Rd STE A, Phoenix 85006
St. Joseph's Hospital and Medical Center
350 West Thomas Rd, Phoenix 85013
Phoenix Children's Hospital
1919 East Thomas Rd, Phoenix 85016
Phoenix
1008 E Mcdowell Rd STE A, Phoenix 85006
St. Joseph's Hospital and Medical Center
350 West Thomas Rd, Phoenix 85013
Phoenix Children's Hospital
1919 East Thomas Rd, Phoenix 85016
Education:
Medical Schools
University Of Arizona College Of Medicine
Graduated: 1997


Kelly Roy Photo 2

Kelly Roy, Phoenix AZ

Work:
Arizona Gynecology Consultants
1008 E Mcdowell Rd, Phoenix, AZ 85006


Kelly Roy Photo 3

Method For Sterilization Using In Situ Gelling Materials

US Patent:
2006014, Jul 6, 2006
Filed:
Sep 15, 2003
Appl. No.:
10/527543
Inventors:
Brent Vernon - Mesa AZ, US
Kelly Roy - Phoenix AZ, US
International Classification:
A61K 31/225
US Classification:
514547000
Abstract:
A method for sterilizing a female or male patient is provided. The method comprises introducing into a reproductive duct of the patient a composition comprising a nucleophilic component, such as a thiol, and a component containing a conjugated unsaturated bond, such as an acrylate. The composition crosslinks within the reproductive duct. Within a female patient, the composition is introduced into one or both uterine tubes. The composition gels in the uterine tubes, thereby blocking the uterine tubes and preventing conception.


Kelly Roy Photo 4

Kelly H Roy

Location:
Phoenix, Arizona Area